type I and fibronectin, and express FSP1 in patterns similar to fibroblasts. Conclusions: Based on currently accepted definitions for cultured human MSCs and fibroblasts, we could not find any immunophenotypic property that could make a characteristic distinction between MSCs and fibroblasts.
Introduction
The cells currently known as mesenchymal stromal/ stem cells (MSCs) were originally discovered by A.J. Friedenstein, and are characterized by their ability to adhere to culture plates, to generate fibroblast-like colonies and to be repeatedly passaged upon proliferation [1] [2] [3] [4] . Furthermore, Friedenstein [3] was the first to show that these stromal cells are responsible for creating the hematopoietic tissue microenvironment, as the transplantation of these cells under the kidney capsule of guinea pigs resulted in not only bone formation, but also transferred the hematopoietic supportive properties of bone marrow (BM) stroma [4] . These cells were originally denoted as colony-forming unit fibroblasts, could also be derived from non-BM organs, and had the ability to differentiate into bone and cartilage tissues [2, 5, 6 ] . While 'mesenchymal stem cell' terminology was later adapted to indicate the multipotential differentiation capabilities of these cells [7, 8] , they are also commonly referred to as 'mesenchymal stromal cells' [9] .
In 2006, the International Society for Cellular Therapy (ISCT) developed a now widely accepted consensus definition for MSCs that includes their ability to adhere to plastic under standard culture conditions, to differentiate in vitro to osteoblasts, adipocytes and chondroblasts, their expression of CD73, CD90 and CD105 and their lack of expression of CD34, CD45, CD14 or CD11b, CD19 or CD79α, and HLA-DR [10] .
Similar to MSCs, fibroblasts are present in almost every human tissue, contribute to wound healing and represent a heterogeneous population of cells [11, 12] . However, in contrast to the recently defined and standardized characteristics of MSCs, there are still no widely accepted criteria for defining fibroblasts [13] , even though the 3T3 cell line established in 1962 has been utilized as the standard fibroblast cell line in innumerable experimental studies [14] .
Over the years, many studies have compared MSCs and fibroblasts, and most of these show that fibroblasts express many of the same markers as MSCs, that they can be induced to differentiate into adipocytes, chondrocytes and osteoblasts and that they even have immunomodulatory properties similar to MSCs [15] [16] [17] [18] [19] [20] [21] [22] . However, there are also publications reporting differences between MSCs and fibroblasts. For example, some studies have shown that fibroblasts are incapable of differentiating into adipocytes, chondrocytes and osteoblasts [8, 19, 23] . Furthermore, another study showed that fibroblasts from foreskin and adult dermis differ from BM MSCs in their expression of CD10, CD26 (both positive in fibroblasts but not in MSCs), CD106 (positive in MSCs but not in fibroblasts) and collagen VII (a 12-fold greater expression in fibroblasts) [23] . In 2 studies that compared global gene expression of MSCs and fibroblasts, 1 found that MSCs express higher levels of genes related to embryogenesis and neural development [24] and the other found that MSCs express more MHC-DR-α, MHC-DR-β and CD73 than fibroblasts, but that fibroblasts express more adrenomedullin, apolipoprotein D, collagen type XV α1 and matrix metalloproteinase-1 [25] . In this study, we selected 4 fibroblast strains that were derived a decade or more ago from different human tissues and have been used by multiple laboratories as paradigms of fibroblast cell lines. We compared the phenotypical characteristics and differentiation capabilities of these fibroblasts to MSCs from human BM or adipose tissue (AT) derived in our laboratory for the purpose of being able to distinguish the 2 populations. Elucidation of the relationship between MSCs and fibroblasts could help to reconcile many of the immunomodulatory and anti-inflammatory properties of MSCs with the corresponding biological effects of fibroblasts in tissue repair following inflammatory injuries.
Materials and Methods

Isolation and Culture of Mesenchymal Stromal/Stem Cells
Human BM and AT MSCs were derived from healthy donors using protocols approved by the UW-Madison Institutional Review Board, as previously described [15, 26] . Briefly, BM mononuclear cells from discarded collection filters after BM donation were separated by density gradient separation using Ficoll-Hypaque (GE Lifesciences, Piscataway, N.J., USA), followed by treatment with ACK lysis buffer to reduce contaminating red blood cells. Cells were collected from AT that was resected or from aspirates from abdominoplasty flaps, after mechanical mincing followed by enzymatic digestion with type I collagenase (Sigma-Aldrich, St. Louis, Mo., USA). BM mononuclear cells or digested AT were grown in αMEM media supplemented with 10% FBS, 1% nonessential amino acids and 2 μ M L -alanyl-L -glutamine (Hyclone, Logan, Utah, USA). Nonadherent cells were discarded within 24 h. Cells were dissociated and passaged 1: 3 upon reaching 80-90% confluency, using TrypLE (Invitrogen, Carlsbad, Calif., USA) per manufacturer's directions. Passages 4-6 were used for experiments.
Culture of Fibroblasts
Neonatal foreskin dermal fibroblasts (PCS-201-010; denoted as 'Foreskin FB 1') [27, 28] and embryonic lung fibroblasts (IMR-90; denoted as 'Lung FB') [29] were obtained from the American Type Culture Collection and cultured according to their protocols. A second strain of neonatal foreskin dermal fibroblasts (AH1F; denoted as 'Foreskin FB 2') [30] was derived originally by Dr. Lynn Allen-Hoffmann at the University of Wisconsin [31] . Mammary fibroblasts (RMF/EG; denoted as 'Breast FB'), kindly provided by Dr. Andreas Freidl of the University of Wisconsin, were originally derived in the Dr. Robert Weinberg Laboratory from tissue obtained at the time of reduction mammoplasty [32] . All 4 fibroblast strains were cultured in DMEM media supplemented with 10% FBS. Passages 4-6 (from receiving from other laboratories) were used for experiments.
Flow Cytometry
Fibroblasts and MSCs were harvested using TrypLE and resuspended at a density of 1 × 10 6 cells per 100 μl PBS, and then incubated with 10 μl surface antibodies (1: 10) for 30 min at 4 ° C in the dark. The following antibodies were used: CD14 FITC, CD19 PE, CD29 PE, CD31 PE, CD34 APC, CD44 PE, CD45 PE, CD73 PE, CD90 PE, CD105 PE, CD206 PE, HLA-ABC FITC and HLA-DR FITC (BD Biosciences, San Jose, Calif., USA). As a control, cells were stained with the appropriate isotype antibodies. Samples were analyzed using an Accuri C6 flow cytometer (Ann Arbor, Mich., USA). FlowJo software (Tree Star) was used to analyze the data.
Differentiation Assays
Fibroblasts and MSCs were plated in 24-well plates and grown to 80-90% confluency. Adipogenic or osteogenic differentiation media (Miltenyi Biotech, Auburn, Calif., USA) was added and changed every 3-4 days for a total of 21 days. Adipocyte lipid droplets were detected by oil red O staining (Sigma-Aldrich). Osteoblast calcification was detected by Alizarin red S staining (SigmaAldrich). For chondrogenic differentiation, 2.5 × 10 5 cells were put in a deep-well, 96-well plate and centrifuged to make a pellet. Media was changed every 3-4 days for a total of 24 days. Pellets were embedded in 2% agar, fixed in formalin and sectioned. Chondrocytes were detected by staining with Alcian blue.
IFNγ Stimulation
Fibroblasts and MSCs were harvested using TrypLE digestion, and 1 × 10 5 cells were plated in 6-well plates in appropriate culture media and stimulated with 100 IU/ml IFNγ. Unstimulated cells served as controls. Cells were harvested after 4 days and analyzed by flow cytometry as described above after staining with HLA-ABC FITC, HLA-DR PE, CD80 FITC and CD86 PE.
T Cell Suppression Assay
Our reference standard BM MSCs [33] and 4 fibroblast strains were plated in titrated numbers. Peripheral blood samples from healthy donors were separated by density centrifugation, and peripheral blood mononuclear cells (PBMCs) were collected and labeled with carboxyfluorescein succinimidyl ester (CFSE, SigmaAldrich) according to the manufacturer's directions. These were cultured alone at a PBMC:MSC/fibroblast ratio of 1: 0 for use as a positive control or cocultured with titrated numbers of fibroblasts or MSCs with PBMC:MSC/fibroblast ratios ranging from 1: 1 down to 1: 0.05. Soluble anti-human CD3 and anti-human CD28 monoclonal antibodies (R&D Systems Inc., Minneapolis, Minn., USA) were used to stimulate T cell populations. After 4 days, cultures were harvested and stained with anti-human CD4 APC (R&D Systems, Inc.). Data acquisition was performed with an Accuri C6 flow cytometer. Percent CD4+ T cell stimulation (% CD4+/ CFSE-low cells) was gauged using the 1: 0.05, nonstimulated, negative-control gate.
Culture of Macrophages
Macrophages were isolated and cultured as previously described [26, 34] . CD14+ cells were plated in IMDM media supplemented with 10% human serum antibody, 1% nonessential amino acids, 2 μ M L -alanyl-L -glutamine, 1% sodium pyruvate and 5 μ M human recombinant insulin, and then cultured for 7 days to allow for differentiation into macrophages. Following this, MSCs or fibroblasts were plated with these macrophages at a 1: 10 ratio (10 5 MSCs:10 6 macrophages in a 6-well plate).
Quantitative Polymerase Chain Reaction RNA was isolated from cells using the RNeasy micro kit (Qiagen, Valencia, Calif., USA) and converted to cDNA using the Quantitect reverse transcription kit (Qiagen). Q-PCR was performed using Power SYBR Green master mix (Applied Biosystems, Foster City, Calif., USA) on a StepOnePlus instrument (Applied Biosystems). Quantification of IL-10 and IL-12 expressed as an mRNA level was normalized to the mRNA of 3 housekeeping genes ( RRN18S , GAPDH and ACTB ). Primers were obtained from Qiagen.
Collagen and Fibronectin Immunocytochemistry
Fibroblasts and MSCs were plated on glass coverslips in 24-well plates. For wells to be analyzed for collagen I, cells were treated with 0.2 m M ascorbate (Sigma-Aldrich). Monolayers were fixed with 3.7% paraformaldehyde in PBS for 10 min, blocked with 1% bovine serum albumin in PBS for 1 h, incubated with rabbit anticollagen I or anti-fibronectin [35] for 1 h, and then incubated with anti-rabbit secondary antibody conjugated with Alexa 546 (Jackson ImmunoResearch Laboratories, West Grove, Pa., USA). Nonspecific rabbit anti-serum was used as a negative control. Coverslips were counterstained for DNA with 4′,6-diamidino-2-phenylindole (DAPI) and mounted with ProLong Gold Antifade reagent (Thermo Fisher, Waltham, Mass., USA). Coverslips were then visualized by fluorescence microscopy with a Nikon Eclipse Ti inverted microscope and CoolSNAP HQ2 charge-coupled-device camera (Photometrics) using the appropriate filters for Alexa 546.
Western Blotting
Equal amounts of protein from cells were electrophoresed on 10% SDS-PAGE gel. The proteins were transferred to PVDF membranes, which were probed with the following antibodies: anti-FSP1 (Millipore, Billerica, Mass., USA) and anti-alpha tubulin (Abcam, Cambridge, Mass., USA). HRP-conjugated goat anti-rabbit secondary antibody was used (Cell Signalling) along with Pierce ECL Western blotting substrate (Thermo Fisher). Protein bands were quantified using ImageJ (NIH, Bethesda, Md., USA).
Results
Fibroblasts and MSCs Share Similar Morphology and Cell Surface Markers
Four fibroblast cell strains from 3 different human tissue sources (breast, foreskin and lung) and MSCs from 2 different human tissue sources (BM and AT) were grown under appropriate culture conditions. MSCs and fibroblasts adhered to plastic under standard cell culture conditions and did not show any discernible differences in morphology on phase-contrast microscopy ( fig. 1 ). We then analyzed fibroblasts for MSC cell surface markers based on ISCT criteria using flow cytometry [10] . All the fibroblasts tested were positive for CD73, CD90 and CD105 and negative for CD14, CD34, CD45, CD19 and HLA-DR, similar to MSCs ( fig. 2 ; online suppl. fig. 1 , see www.karger.com/doi/10.1159/000445096 for all online suppl. material). We also analyzed additional markers that are characteristic of MSCs but are not part of the ISCT consensus criteria; we found that all the fibroblasts were positive for CD29 and CD44 and negative for CD31, similar to MSCs ( fig. 2 ; online suppl. fig. 1 ).
Fibroblasts Differentiate into Adipocytes, Chondrocytes and Osteoblasts
The third criterion that defines an MSC is the ability to differentiate in vitro into adipocytes, chondrocytes and osteoblasts [10] . Therefore, we investigated whether or not fibroblasts could differentiate into these 3 cell types. Fibroblasts and MSCs were grown in adipogenic, chondrogenic and osteogenic conditions, as described in Materials and Methods. Adipocyte lipid droplets were stained with oil red O, osteoblast calcium deposits with Alizarin red S and paraffin-embedded chondrocyte pellets with Alcian blue. Similar to MSCs, all 4 fibroblast cell strains were able to differentiate into adipocytes, chondrocytes and osteoblasts ( fig. 3 ) .
Fibroblasts Express HLA-DR after IFNγ Stimulation
Unstimulated fibroblasts and MSCs were positive for HLA-ABC and negative for HLA-DR and the costimulatory molecules CD80 and CD86. MSCs are known to express the major histocompatibility complex class II, HLA-DR, following stimulation with IFNγ [10] . Fibroblasts stimulated with IFNγ expressed HLA-DR, similar to MSCs stimulated with IFNγ ( fig. 4 ) . 
Fibroblasts and MSCs Share Immunomodulatory Properties
MSCs are well-known to suppress T cell proliferation [36] . We sought to determine whether fibroblast strains from different tissues could also inhibit CD4+ T cell proliferation. We used a BM MSC strain that we established at our laboratory as our reference standard for MSC immunosuppression [33] . For this assay, PBMCs were stained with CFSE and stimulated with anti-CD3 and anti-CD28 antibodies. Fibroblasts or MSCs were cocultured with CFSE-labeled PBMCs at PBMC:MSC/fibroblast ratios ranging from 1: 1 down to 1: 0.05 and 1: 0 ratios (PBMCs cultured without MSCs or fibroblasts) were used in positive controls. Nonstimulated, 1: 0.05 ratios were used in negative controls, such that gates could be set to measure the extent of proliferation for the other (stimulated) cultures. After a 4-day incubation period, flow cytometry was used to analyze the percent of CFSE low (proliferative) CD4+ T cells. Fibroblasts were able to suppress CD4+ T cell proliferation levels similar to that of our reference BM MSCs at all ratios tested ( fig. 5 ). Nonstimulated cocultures (without anti-CD3 and anti-CD28 antibodies) demonstrated that fibroblasts, like MSCs, were not immunostimulatory in and of themselves.
We have previously shown that MSCs are able to modulate the immunophenotype of macrophages toward a unique type of alternatively activated macrophages, which are characterized by increased expression of CD206, high expression of IL-10 and low expression of IL-12 [26] . We cocultured macrophages with fibroblasts and MSCs for 3 days and analyzed the expression of CD206 by flow cytometry. We found that all fibroblast strains, similar to MSCs, were able to increase CD206 expression in macrophages ( fig. 6 a) . Furthermore, fibroblasts cultured with macrophages in transwell experiments induced macrophages to express more IL-10 and less IL-12, as seen in MSC-educated macrophages ( fig. 6 b) . 
MSCs Exhibit Immunohistochemical Properties Characteristic of Fibroblasts
Fibroblasts are typically characterized by their ability to produce fibronectin and collagen matrices, so we investigated whether MSCs produce similar extracellular matrices. BM-and AT-derived MSCs, each from 3 different donors, were utilized for these experiments and were compared to the 4 different fibroblast strains. Fibroblasts and MSCs were plated on coverslips in 24-well cluster dishes for 3 days and examined by fluorescence microscopy. The fibronectin and collagen type I matrices produced by fibroblasts and MSCs both varied slightly depending on the tissue of origin, but there were no obvious differences that could be used to distinguish fibroblasts from MSCs ( fig. 7 ) .
Some reports suggest that the fibroblast-specific protein 1 (FSP1), a cytoplasmic filament-associated, calcium-binding protein, is a specific marker for fibroblasts [37] [38] [39] . Therefore, we analyzed FSP1 expression in fibroblasts and MSCs by Western blotting, and there were no obvious differences (online suppl. fig. 2 ). The differences in FSP1 expression among the fibroblast strains were comparable to the differences in FSP1 expression among the MSC strains.
Discussion
We provide evidence that fibroblasts and MSCs could not be distinguished phenotypically, based on their morphology, cell surface markers, differentiation potential and immunomodulatory properties. We demonstrate that 4 well-established fibroblast strains express all the cell surface markers of the ISCT consensus criteria that are used to define MSCs [10] , and that they are also capable of differentiating into adipocytes, chondrocytes and osteoblasts. Additionally, we show that the extracellular matrix secreted by MSCs is similar to that secreted by fibroblasts [40, 41] . We also show that the 4 fibroblast lines we tested can suppress T cell proliferation in vitro and also change the immunophenotype of macrophages, similar to the MSC-mediated alternative activation of macrophages [26] . The latter observation is intriguing as it could provide an explanation for how anti-inflammatory properties of MSCs are reminiscent of fibroblast proliferation during a wound healing process in vivo, as fibroblasts are presumed to orchestrate the resolution of the inflammatory process via converting inflammatory macrophages to anti-inflammatory macrophages [41, 42] . We previously investigated the characteristics of vocal-fold fibroblasts and found that they have the same cell surface markers, differentiation potential and immunologic properties as BM-and AT-derived MSCs [15] . Our results are supported by numerous previous studies. It has been shown that fibroblasts from the human bronchus, dermis and foreskin are similar to BM-derived MSCs with regard to their cell surface markers [16, 17, [43] [44] [45] [46] . Many reports have also demonstrated the ability of fibroblasts from different tissues, including the dermis, lung and orbit, to differentiate into adipocytes, chondrocytes and osteoblasts [16-19, 43, 45, 47-49] . Furthermore, dermal and foreskin fibroblasts have been shown to suppress T cell proliferation [20, 23, 50, 51] . Interestingly, as long as 30 years ago, fibroblasts were found to suppress lymphocytes via a PGE 2 -dependent mechanism [52] , which is now known to partially confer the immunomodulatory properties of MSCs [53] . In addition, large-scale gene expression profiles demonstrate that fibroblasts and MSCs from a number of different sources show very similar patterns [19] .
Prior studies have also presented evidence that MSCs exhibit properties typically thought to characterize fibroblasts. One showed that BM MSCs express the same types of collagens as skin fibroblasts [54] . Others demonstrated that BM and AT MSCs make collagen, fibronectin, and nestin matrices similar to those of dermal, bronchial, and fetal lung fibroblasts [16, 17] .
While some studies have shown certain similarities between MSCs and fibroblasts, the literature is beset by contrary reports. For example, Pittenger et al. [8] and Cappellesso-Fleury et al. [23] demonstrated that fibro- Immunophenotype of fibroblast-educated macrophages. a CD14+ cells were isolated from peripheral blood of 3 different donors and plated in 6-well plates (1 × 10 6 /well) for 7 days to allow for differentiation into macrophages. Then fibroblasts or MSCs (2 × 10 5 /well) were added and cocultured for 3 days. Macrophages were harvested by scraping the plates. Cells were stained with anti-CD14 and anti-CD206, and the CD206 expression was analyzed in CD14-positive cells. Representative histograms are shown. The bar graph represents the average CD206 mean channel fluorescence in units relative to the control (no MSCs or fibroblasts added to CD14+ cells) ± SE from 3 independent experiments. b Q-PCR was used to assess gene expression of IL-10 and IL-12 normalized to 3 housekeeping genes ( RRN18S , GAPDH and ACTB ). Relative mRNA levels (2^-ΔCt) are plotted. Samples were analyzed in triplicate, and bars represent means ± SE. MQ = Macrophage. * p < 0.05 compared to control. [15, 16] . Some studies suggest that such differentiation capability may depend on the tissue of origin; for example, Covas et al. [19] showed that skin fibroblasts, but not foreskin fibroblasts, are capable of differentiating into adipocytes, chondrocytes and osteoblasts. Several large-scale gene expression studies comparing MSCs and fibroblasts have also noted some differences in a variety of genes [24, 25] . However, it is also well known that even fibroblasts display distinct and characteristic transcriptional gene expression patterns depending on the anatomic site or origin [55, 56] . Furthermore, the magnitude of the differences reported in the literature between MSCs and fibroblasts is comparable to differences reported in the literature among MSCs derived from different tissues. In studies where fibroblasts and MSCs have been reported to be different, these differences are no greater than the differences between MSCs from different tissues or between fibroblasts from different tissues [18] . Given that differences in culture conditions or derivation methodologies could affect the phenotype of these cells [57, 58] , it is not surprising that such differences are found in gene expression studies that compare MSCs and fibroblasts. Thus, neither the MSC criteria established by the ISCT, including cell surface markers and differentiation capabilities, nor the immunohistochemical properties characteristic of fibroblasts are capable of clearly distinguishing MSCs from fibroblasts. We found that fibroblasts meet all the criteria set forth by the ISCT for defining MSCs, and, conversely, our assays show that MSCs display fibroblast immunohistochemical characteristics. Importantly, recent in vivo data is emerging in the literature that point to MSC-like cells as a major cellular origin of fibrosis by demonstrating that perivascular Gli1(+) cells in mice express a typical MSC marker pattern in many organs, are plastic adherent and can differentiate into adipocytes, chondrocytes and osteoblasts in vitro [59] . Importantly, after organ injury, resident Gli1(+) cells expand and become myofibroblasts and contribute to organ fibrosis.
As we and other study groups have proposed, fibrosis is an evolutionarily conserved defense mechanism against many different pathologies, via which fibrosis is the consequence of (myo)fibroblast cell efforts to suppress inflammation [60, 61] . This could provide an explanation for why MSC/fibroblasts have such a wide range of immunomodulatory and anti-inflammatory properties, both in vitro and in vivo. We propose that MSCs and fibroblasts could not be distinguished based on the commonly used phenotypic characterization methodologies and could likely represent the same cell type.
Conclusions
Fibroblasts and MSCs cannot be distinguished from each other, based on examination of their morphology, cell surface markers, differentiation potential or immunomodulatory properties. Notably, fibroblasts share immunomodulatory properties with MSCs, such as the suppression of T cell proliferation and the modulation of macrophage immunophenotype. Our results suggest that MSCs and fibroblasts could likely represent the same cell type.
